Skip to search formSkip to main contentSkip to account menu

hydroxyprogesterone caproate (USP)

Known as: caproate hydroxyprogesterone, 17-alpha-hydroxy-progesterone caproate, Hydroxyprogesterone Caproate 
A synthetic progestational agent similar to the endogenous progesterone used in hormone therapy or as a female contraceptive. Mimicking the action of… 
National Institutes of Health

Related topics

Related topics

21 relations
1 ML hydroxyprogesterone caproate (USP) 250 MG/ML Injection [Makena]AmenorrheaDrug AllergyEndometriosis

Broader (4)

17-alpha-HydroxyprogesteroneEstrogen AntagonistsHydroxyprogesteronesProgestins

Narrower (4)

DelalutinMakenaNeolutinProlutin Depot

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?
Review
2009
Review
2009
Comparing diagnostic methods for mental disorders in China
2008
2008
17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery.
We evaluated if the inhibitory effect of 17alpha-hydroxyprogesterone caproate (17P) on cervical ripening is mediated by cervical… 
2007
2007
Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
2005
2005
Polyunsaturated fatty acids and risk of preterm delivery.
Preterm delivery (PD) is characterized both by increased neonatal morbidity and mortality and by important late pathologic… 
1993
1993
Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the…
1982
1982
Evaluation of the use of prolution‐depot (hydroxyprogesterone hexanoate) in early pregnancy
1979
1979
High‐Risk Prematurity—Progestin Treatment and Steroid Studies
Studies have been undertaken regarding the efficacy and modus operandi of 17α-hydroxyprogesterone caproate (17α-OHP-C) in… 
Highly Cited
1971
Highly Cited
1971
Hydroxyprogesterone caproate therapy in advanced endometrial cancer
In 314 women with advanced progressing adenocarcinoma of the uterine corpus (endometrial cancer) no longer responding to… 
1961
1961
Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometral carcinoma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)